Power Life Sciences Inc.
Historically, research participation has been biased toward certain demographics. However, there is a shortage of studies that delve into the underlying factors that influence patient participation, both positively and negatively. Several people will be invited to enroll in this study so that it may collect a variety of data about schizophrenia clinical trial experiences and identify barriers to participation as well as the causes of participants' failure or withdrawal. The data collected from this study will be analyzed and used to improve the experiences of future schizophrenia patients who are recruited for medical trials.
Schizophrenia
| Study Type : | Observational |
| Estimated Enrollment : | 500 participants |
| Official Title : | Pinpointing the Factors Affecting Clinical Study Experiences of Schizophrenia Patients |
| Actual Study Start Date : | June 2024 |
| Estimated Primary Completion Date : | June 2025 |
| Estimated Study Completion Date : | June 2026 |
Information not available for Arms and Intervention/treatment
| Ages Eligible for Study: | 18 Years |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.